Avastin Needs Quality Of Life Data In Confirmatory Glioblastoma Trial – Cmte.

Quality of life issues could be incorporated into a Phase III confirmatory study for Genentech's Avastin in treatment of glioblastoma multiforme, following suggestions by members of FDA's Oncologic Drugs Advisory Committee